Madrigal shares triple on positive NASH study results

Madrigal shares triple on positive NASH study results

Source: 
BioPharma Dive
snippet: 

Shares of Madrigal Pharmaceuticals more than tripled in value Monday after the Pennsylvania-based drugmaker said its experimental treatment for a common liver disease succeeded in a closely watched clinical trial.